In terms of Regulation 33 read with Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (the ‘Listing Regulations’), Welcure Drugs & Pharmaceuticals has informed that the Board of Directors of the Company in their meeting held today Monday, April 26, 2021 at 01:30 pm and concluded at 03:00 pm approved the following: Audited Financial Results for the Quarter & Financial Year ended March 31, 2021 along with Auditors report thereon, appointment of Vibhor Gupta & Associates as an Internal Auditor of the Company for the financial year 2021-22, and appointment of A.K. Nandwani & Associates as a Secretarial Auditor of the Company for the financial year 2021-22. Further, the company has declared that pursuant to Regulation 33(3) (d) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 as amended till date, the Reports of Auditors are with unmodified opinion with respect to the Audited Financial Results of the Company for the quarter and year ended March 31, 2021.
The above information is a part of company’s filings submitted to BSE.
Company Name | CMP |
---|---|
Redington | 202.20 |
Adani Enterprises | 2409.25 |
Amrapali Industries | 17.58 |
Rashi Peripheral | 402.95 |
Compuage Infocom | 3.05 |
View more.. |